INSIGHTS ON DRUG DEVELOPMENT
-
![GettyImages-1465073074 tablets, OSD, pills]( "Calcium Carbonate Vs Titanium Dioxide: Why Particle Engineering Matter")
Calcium Carbonate Vs Titanium Dioxide: Why Particle Engineering MatterDiscover how particle-engineered calcium carbonate offers a viable alternative to titanium dioxide in tablet coatings, achieving good opacity, process efficiency, and comparable tablet properties.
-
![GettyImages-2189405678-GLP-1-drugs-magnifying-glass]( "Development Of Separation Methods for GLP-1 Synthetic Peptides")
Development Of Separation Methods for GLP-1 Synthetic PeptidesPeptides offer precise, low-cost therapeutic potential, especially in GLP-1 drugs for diabetes and weight loss. A new HPLC-UV/MS method ensures consistent quality and analysis of these compounds.
-
![Validation strategies]( "Validating Antibodies With Knock-Out Technologies")
Validating Antibodies With Knock-Out TechnologiesWatch to learn about how one company achieves antibody validation through knock-out (KO) technologies as well as the significance of gene KO technologies in the large-scale screening of antibodies.
-
![GettyImages-673804426 aseptic biologics clean room lab]( "Biologic Stability: A Thermofluor Screen For Rational Buffer Optimization")
Biologic Stability: A Thermofluor Screen For Rational Buffer OptimizationLearn how thermal shift fluorimetry (thermofluor) can be used as a rapid, low-volume, and cost-effective technique to accelerate buffer optimization and enhance protein stability.
-
API In Capsule Vs. The Lost Art Of Formulation Development11/5/2025
API-in-capsule offers a fast path for early clinical data, but it can't eliminate the need for full formulation development. Weighing the potential for higher total development time and cost is critical.
-
From 51% Yield To 87% With Targeted Impurity Removal5/7/2026
Targeted impurity identification and purification redesign dramatically improved yield, reduced process complexity, and enabled reliable API supply for Phase II clinical development.
-
Overcoming Challenges In Ophthalmic Formulations Through Polymer Selection8/27/2025
The growing demand for ophthalmic drugs is driven by aging populations and increased screen time, which contributes to rising eye conditions. Explore innovative solutions in ophthalmic drug development.
-
Analyzing Biological Drug Effects In 3D10/24/2025
Explore how 3D tumor microtissues paired with fluorescence-based assays offer scalable, high-sensitivity drug testing to deliver stronger signals and reproducible results compared to monolayer cultures.
-
Patented Process For Intermediates Useful For Etrasimod Arginine3/13/2026
Explore how rethinking the synthetic strategy for Etrasimod can overcome the limitations of legacy routes, enabling more efficient chirality control, improved scalability, and more practical industrial API production.
DRUG DEVELOPMENT SOLUTIONS
-
![GettyImages-1306664598 lab research]( "Bionanoparticle Technology")
Nanoform’s proprietary bionanoparticle technology can deliver large-molecule drug particles as small as 50 nm while retaining biological activity. This can not only enable more patient-friendly approaches to drug delivery, but also potentially higher loads of active ingredients.
-
![White Tablets-GettyImages-172969989]( "Enhanced Opacity With Ideal Particle Properties")
Titanium dioxide is extensively used in solid dosage forms as an opacifier and colorant. Due to regulatory developments and restrictions by authorities, formulators are increasingly interested in titanium dioxide-free solutions for both dietary supplements and medicinal products. Uniform colored and white coatings applied to tablets not only have an aesthetic function but also improve patient compliance.
-
![BAB400 Bioprinter]( "Automated Bioprinting Solution For High-Content Screening")
Automated bioprinting solution for high-content screening with the BAB400 bioprinter for optimized 3D tissue and organoid workflow.
-
![GettyImages-1096502334-lab-microscope-research]( "R&D And Analytical Services")
Our team of analytical experts provides experience, efficiency, and technical proficiency in the development/validation of analytical methodology and GMP testing support for your project.
-
![Method Selection Suite™]( "Develop Chromatographic Methods Faster With Prediction Software")
Your Method Development Toolbox
ACD/Method Selection Suite is your software assistant for LC and GC method development. When you want to develop methods using Quality by Design (QbD) principles, and make every experiment count, reach for Method Selection Suite to:
- Choose your starting conditions and columns
- Simulate separations under new conditions
- Optimize your chromatography with 1D, 2D, or 3D models
- Predict the retention times of new compounds
- Database successful methods for future use
